We are live on ! Find out more
FFVM

Founders Fund VII Management Portfolio holdings

AUM $2.03M
1-Year Est. Return 72.34%
This Fund
S&P 500
This Quarter Est. Return
-28.37%
1 Year Est. Return
+72.34%
3 Year Est. Return
-64.66%
5 Year Est. Return
-90.66%
10 Year Est. Return
AUM
$60.1M
AUM Growth
-$27.7M
Cap. Flow
-$4.12M
Cap. Flow %
-6.86%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CMPS
Compass Pathways
CMPS
+$4.12M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCL icon
1
AbCellera Biologics
ABCL
$3.99B
$54M 89.75%
3,773,530
CMPS
2
Compass Pathways
CMPS
$2.04B
$6.16M 10.25%
278,880
-129,530
-32% -$4.12M

Similar funds

Founders Fund VII Management's Q4 2021 Portfolio in Review

As of Q4 2021, Founders Fund VII Management held 2 positions worth $60.1M, down 32% from $87.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Founders Fund VII Management withdrew a net $4.12M in Q4 2021, reducing 1 holding. Its largest reduction was Compass Pathways, cutting an estimated $4.12M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Founders Fund VII Management's biggest Q4 2021 reduction was Compass Pathways, cutting an estimated $4.12M.
  • Founders Fund VII Management's ten largest holdings make up 100% of its $60.1M portfolio in Q4 2021.
  • Founders Fund VII Management opened 0 new positions and closed 0 in Q4 2021.
  • Founders Fund VII Management's portfolio value fell 32% quarter-over-quarter to $60.1M.

Based on Founders Fund VII Management's 13F filing for Q4 2021, filed 14 Feb 2022.